Van ECK Associates Corp bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 16,622 shares of the exchange traded fund’s stock, valued at approximately $1,497,000.
Other large investors have also recently added to or reduced their stakes in the company. Golden State Wealth Management LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth approximately $29,000. Avior Wealth Management LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 393.6% during the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after buying an additional 307 shares during the last quarter. Tidemark LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after buying an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. acquired a new position in shares of SPDR S&P Biotech ETF during the third quarter worth approximately $40,000. Finally, Howe & Rusling Inc. acquired a new position in shares of SPDR S&P Biotech ETF during the third quarter worth approximately $49,000.
SPDR S&P Biotech ETF Stock Down 1.1 %
Shares of XBI stock opened at $91.70 on Friday. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The firm has a market cap of $6.99 billion, a PE ratio of 11.47 and a beta of 1.11. The stock has a 50 day moving average of $91.36 and a 200-day moving average of $95.97.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- Learn Technical Analysis Skills to Master the Stock Market
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- What does consumer price index measure?
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.